Tom Thomson

935 citations

23 papers · 730 indexed · h-index 15

Impact in

Dermatology top 5%
- Cancer and Skin Lesions
Transplantation top 10%

Papers in ⓘ

Dermatology 4
- Cancer and Skin Lesions 4
Physiology 2
- Adenosine and Purinergic Signaling 2

Co-authors: Steven Tang (2 shared papers)Brenda Lomax (1 shared paper)Don R. Phillips (2 shared papers)C. Blake Gilks (3 shared papers)Adam P. Curnock (3 shared papers)Richard A. Williamson (3 shared papers)Christopher Yea (3 shared papers)Robert Westwood (3 shared papers)
Journals: Radiotherapy and Oncology (2 papers)Archives of Pathology & Laboratory Medicine (2 papers)Journal of Pharmacology and Experimental Therapeutics (1 paper)Clinical Breast Cancer (1 paper)Annals of the Rheumatic Diseases (1 paper)
Partner nations: Canada France United Kingdom

In The Last Decade

Tom Thomson

23 papers receiving 691 citations

Peers

Countries citing papers authored by Tom Thomson

Since Specialization

Citations

This map shows the geographic impact of Tom Thomson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Thomson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Thomson more than expected).

Fields of papers citing papers by Tom Thomson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Thomson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Thomson. The network helps show where Tom Thomson may publish in the future.

Co-authors

The 25 scholars most cited alongside Tom Thomson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tom Thomson Line = papers co-authored together Tom Thomson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Dihydroorotate Dehydrogenase Is a High Affinity Binding Protein for A77 1726 and Mediator of a Range of Biological Effects of the Immunomodulatory Compound Journal of Biological Chemistry ·Richard A. Williamson, Christopher Yea, P.A. Robson, Adam P. Curnock, Suresh Jivan Gadher, Anne B. Hambleton, Katherine Woodward, Jean‐Michel Bruneau, P. Hambleton, David S. Moss, Tom Thomson, S Spinella-Jaegle, Philippe Morand, Olivier Courtin, Catherine Sautès‐Fridman, Robert Westwood, Thierry Hercend, Elizabeth Kuo, E. Ruuth	1995	173
2	Comparative Genomic Hybridization in Combination with Flow Cytometry Improves Results of Cytogenetic Analysis of Spontaneous Abortions The American Journal of Human Genetics ·Brenda Lomax, Steven Tang, Evica Rajcan Separovic, Don R. Phillips, E. Hillard, Tom Thomson, Dagmar K. Kalousek	2000	126
3	Prognostic Factors in Pagetʼs Disease of the Vulva International Journal of Gynecological Pathology ·Denise Crawford, Michael Nimmo, Philip B. Clement, Tom Thomson, John L. Benedet, Dianne Miller, C. Blake Gilks	1999	75
4	Can cytology accurately predict benign follicular nodules? The American Journal of Surgery ·Jenni Smith, Rona Cheifetz, Nathan P. Schneidereit, Kenneth W. Berean, Tom Thomson	2005	53
5	Updated Recommendations from the Canadian National Consensus Meeting on HER2/neu Testing in Breast Cancer Current Oncology ·Wedad Hanna, F. O’Malley, Penny J. Barnes, Richard Berendt, Louis Gaboury, Anthony M. Magliocco, Norman M. Pettigrew, Susan J. Robertson, Sandip Sengupta, Bernard Têtu, Tom Thomson	2007	50
6	Molecular subtype profiling of invasive breast cancers weakly positive for estrogen receptor Breast Cancer Research and Treatment ·Brandon S. Sheffield, Zuzana Kos, Karama Asleh, Xiu Qing Wang, Samuel Leung, Dongxia Gao, Jennifer Won, Christine Chow, Rakesh Rachamadugu, Inge J. Stijleman, Robert Wolber, C. Blake Gilks, Nickolas Myles, Tom Thomson, Malcolm Hayes, Philip S. Bernard, Torsten O. Nielsen, Stephen Chia	2016	27
7	Cytogenetic and cytologic features of chondroid lipoma of soft tissue. PubMed ·Tom Thomson, Douglas E. Horsman, Terry C. Bainbridge	1999	25
8	Inhibition of interleukin 1 beta induced rat and human cartilage degradation in vitro by the metalloproteinase inhibitor U27391. Annals of the Rheumatic Diseases ·Michael Seed, S Ismaiel, Chi Yuen Cheung, Tom Thomson, Colin Gardner, Roger M. Atkins, C J Elson	1993	25
9	HER2 testing in a population-based study of patients with metastatic breast cancer treated with trastuzumab. Archives of Pathology & Laboratory Medicine ·Frances P. O’Malley, Tom Thomson, Jim A. Julian, Cherry Have, Roxanne Cosby, (unknown), Karen A. Gelmon, Irene L. Andrulis, Timothy J. Whelan	2008	23
10	Molecular Predictive Factors in Patients Receiving Trastuzumab-Based Chemotherapy for Metastatic Disease Clinical Breast Cancer ·Andrew Robinson, Dmitry Turbin, Tom Thomson, Erika Yorida, Susan Ellard, Chris Bajdik, David G. Huntsman, Karen A. Gelmon	2006	22
11	Impact of nicotinamide on human tumour hypoxic fraction measured using the comet assay Radiotherapy and Oncology ·Duncan B. McLaren, Tom Pickles, Tom Thomson, Peggy L. Olive	1997	19
12	HER2 Testing in a Population-Based Study of Patients With Metastatic Breast Cancer Treated With Trastuzumab Archives of Pathology & Laboratory Medicine ·Frances P. O’Malley, Tom Thomson, Jim A. Julian, Cherry Have, Roxanne Cosby, Karen A. Gelmon, Irene L. Andrulis, Timothy J. Whelan	2008	19
13	Secretory carcinoma of the major salivary gland: Provincial population‐based analysis of clinical behavior and outcomes Head & Neck ·G. Ayre, Martin Hyrcza, Jonn Wu, Eric Berthelet, Alena Skálová, Tom Thomson	2018	18
14	Potencies of Leflunomide and HR325 as Inhibitors of Prostaglandin Endoperoxide H Synthase-1 and -2: Comparison with Nonsteroidal Anti-Inflammatory Drugs Journal of Pharmacology and Experimental Therapeutics ·Adam P. Curnock, P.A. Robson, Christopher Yea, David S. Moss, Suresh Jivan Gadher, Tom Thomson, Robert Westwood, E. Ruuth, Richard A. Williamson	1997	14
15	LARYNGEAL MALIGNANCY FOLLOWING IODINE-125 THERAPY FOR THYROTOXICOSIS The Lancet ·J. H. McKillop, J. S. Kennedy, J. A. Doig, Tom Thomson, W. R. Greig	1978	14
16	Carcinoma Ex Pleomorphic Adenoma: Case Report and Options for Systemic Therapy Current Oncology ·Negar Chooback, Yaoqing Shen, Martin Jones, L. Sylvia, M. Martin, Tony Ng, Tom Thomson, Marco A. Marra, Janessa Laskin, Cheryl Ho	2017	11
17	Relationship between structure and efficacy at central benzodiazepine receptors for a series of imidazopyrimidines and imidazoquinolines Drug Development Research ·Colin Gardner, Paula Budhram, Robert M. J. Deacon, Tom Thomson	1991	10
18	Inhibition of stimulated Jurkat cell adenosine 3′,5′-cyclic monophosphate synthesis by the immunomodulatory compound HR32577Abbreviations: PGE2, prostaglandin E2; FKN, forskolin; CTX, cholera toxin; cAMP, adenosine 3′,5′-cyclic monophosphate; IBMX, 3-isobutyl-1-methylxanthine; NCA, niclosamide; FCCP, carbonyl cyanide p-trifluoromethoxyphenyl hydrazone; DHO-DH, dihydroorotate dehydrogenase; IL-2, interleukin-2; and HBSS, Hanks’ balanced salt solution. Biochemical Pharmacology ·Adam P. Curnock, Tom Thomson, Robert Westwood, Elizabeth Kuo, Richard A. Williamson, Christopher Yea, Erik Ruuthb	2001	8
19	Differential interactions of Ro 15-4513 with benzodiazepines, ethanol and pentobarbital European Journal of Pharmacology ·Robert Michael John Deacon, Paula Budhram, Tom Thomson, Colin R. Gardner	1990	6
20	Prognostic Factors in Paget’s Disease of the Vulva: A Study of 21 Cases Obstetrical & Gynecological Survey ·Denise Crawford, Michael Nimmo, Philip B. Clement, Tom Thomson, John L. Benedet, Dianne Miller, C. Blake Gilks	2000	5

About Tom Thomson

Tom Thomson is a scholar working on Dermatology, Physiology, Oncology, Cancer Research and Otorhinolaryngology, having authored 23 papers that have together received 730 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Cancer and Skin Lesions (4 papers), Biochemical and Molecular Research (3 papers), Breast Cancer Treatment Studies (2 papers), Adenosine and Purinergic Signaling (2 papers), Salivary Gland Tumors Diagnosis and Treatment (2 papers) and Ear and Head Tumors (2 papers). The work is most often cited by research in Dermatology (87 citations), Transplantation (22 citations), Cancer Research (115 citations), Oncology (206 citations) and Pediatrics, Perinatology and Child Health (124 citations). Tom Thomson has collaborated with scholars based in Canada, France and United Kingdom. Frequent co-authors include Steven Tang, Brenda Lomax, Don R. Phillips, C. Blake Gilks, Adam P. Curnock, Richard A. Williamson, Christopher Yea, Robert Westwood, Rona Cheifetz and P.A. Robson. Their work appears in journals such as Radiotherapy and Oncology, Archives of Pathology & Laboratory Medicine, Journal of Pharmacology and Experimental Therapeutics, Clinical Breast Cancer and Annals of the Rheumatic Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact